prognosis of patients with primary gastric carcinoma [1][2][3]. In cases of advanced gastric cancer with invasion of the serosa, even when there is no clinicopathological evidence of metastasis to regional lymph nodes and to distant sites, many patients still die of recurrence of the tumor during follow-up. Recent studies have demonstrated that patients with stage II gastric cancer benefit significantly from D2 lymphadenectomy [4]. In theory, it seems unlikly that patients with no metastasis to lymph nodes would experience postoperative recurrence of the tumor and should benefit from surgical resection of large numbers of uninvolved lymph nodes. Recent advances in histochemical and molecular biological techniques now allow identification of so-called occult involvement of lymph nodes in cases of breast and colorectal cancers that is generally not detected after standard hematoxylin and eosin (H&E) staining [5][6][7][8][9][10]. In this study, we tried to determine the extent of such occult involvement in lymph nodes by immunostaining of cytokeratin with the CAM 5.2 monoclonal antibody. We then evaluated the clinicopathological significance of such immunostaining in improving the accuracy of diagnosis and the prediction of prognosis for patients with locally advanced gastric cancer.
Patients and methodsA total of 83 patients with stage II gastric cancer who had undergone surgery in our hospital from 1976 to 1992 were included in this study. Patients were subjected to curative total (29 cases) or subtotal (54 cases) gastrectomy with D2 lymphadenectomy, which included the resection of group 1 and group 2 lymph nodes. Group 1 consists of all perigastric nodes. Group 2 consists of the nodes along the left gastric artery, along the common hepatic artery, around the celiac artery, at the splenic hilum, and along the splenic artery. Clinico-
Abstract:Background. In cases of pT3 gastric cancer, even when standard histological staining reveals no evidence of metastases in the regional lymph nodes, patients still may die of postoperative recurrence of the tumor. An attempt was made in the present study to explain the unfavorable outcome of such patients by investigating the presence of occult cancer cells in lymph nodes by immunostaining of cytokeratin. Methods. We examined 2310 lymph nodes that had been removed from 83 patients with stage II gastric cancer (pT3, N0, M0). Two consecutive sections of 4 µm thick were prepared for simultaneous staining with hematoxylin and eosin and immunostaining with the CAM 5.2 monoclonal antibody against cytokeratin, respectively. Results. Evidence of occult involvement was found in 299 of 2310 (13%) lymph nodes and in 54 of 83 (65%) patients with pT3 gastric cancer. An analysis of survival demonstrated the limited 5-year survival of patients with occult involvement in their resected lymph nodes, as compared with that of patients without involvement (P < 0.01). Moreover, the patients in whom group 2 lymph nodes had occult cancer cells had a significantly poorer prognosis than those in whom...